Compassionate Use – Discover Pharma

Welcome to Discover Pharma! Today is : October 12, 2026

Compassionate Use

Advanced Therapies,Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
NIH funds expanded access programme for Neurizon’s ALS therapy
A US National Institutes of Health grant will fund an [...]

September 16, 2026
Advanced Therapies,Clinical & Regulatory,Therapeutic Areas
Rare bone disorder: Novadip reports long-term success for pediatric patients treated under compassionate use programme
Novadip Biosciences and Cliniques universitaires Saint-Luc have reported successful long-term [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development
Novadip’s autologous cell therapy NVD003 receives RMAT designation for rare pediatric bone disorder
FDA recognises regenerative approach for congenital pseudarthrosis of the tibia [...]

May 5, 2026
Drug Delivery & Formulation
FDA approves compassionate use of reverse hip replacement system for spinal fusion patients
April 24, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK